Side Pole Static Ankle Foot Orthosis in Children With Neurological Disorders

Use and Tolerability of a Side Pole Static Ankle Foot Orthosis in Children With Neurological Disorders

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03146598

Acronym

SPS-AFO

Enrollment

100

Registered

2017-05-10

Start date

2012-01-01

Completion date

2012-01-01

Last updated

2017-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurological Disorder

Keywords

Foot deformity, Orthopaedic management, prevention, side pole static ankle foot orthosis

Brief summary

Transverse-plane foot deformities are a frequently encountered issue in children with neurological disorders. They are the source of many symptoms, such as pain and walking difficulties, making their prevention very important. It is thus important to prevent the occurrence of transverse-plane foot deformities and limit their development regarding the high risk of morbidity. In order to prevent such deformities, in the department of pediatric physical medicine and rehabilitation department of Lyon, since 2001 the investigator use a side pole static ankle foot orthosis (SPS AFO) in children with a neurological disorder predisposing such deformities. The aim of the study this study is to describe the use, tolerability and potential side effects of this orthosis in children with neurological disorders from the investigator's department

Interventions

OTHERNo intervention as it is a observational study

No intervention as it is a observational study

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Years to 16 Years

Healthy volunteers

Inclusion criteria

* regularly follow-up in the department of physical medicine and pediatric rehabilitation L'Escale (Lyon, France) * presenting at least unilateral transverse-plane foot deformity within the context of a neurological disorder * having a first prescription of SPS AFO between December 2001 and December 2011.

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame	Description
Duration of the SPS AFO wearing	At 3 months after SPS AFO implementation	Duration of the SPS AFO wearing

Secondary

Measure	Time frame	Description
Frequency of the SPS AFO wearing	At 3 months after SPS AFO implementation	Frequency of the SPS AFO wearing
Duration of the SPS AFO wearing	At 1 year after SPS AFO implementation	Duration of the SPS AFO wearing

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026